Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae

Clinical Microbiology and Infection

Volumn 7, Issue 12, 2001, Pages 661-665

  Murbach, V ^a   Dhoyen, N ^a   Linger, L ^a   Monteil, H ^a   Jehl, F ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Clavulanic acid; Post lactamase inhibitor effect; lactamases

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CLAVULANIC ACID; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GROWTH INHIBITION; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; INOCULATION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 0035746847     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00336.x     Document Type: Article

References (17)

1. The Post-Antibiotic Effect
2. Postantibiotic effect of imipenem on Pseudomonas aeruginosa
3. β-lactamase inhibitors from laboratory to clinic
4. Effect of low concentrations of clavulanic acid on the in vitro activity of amoxycillin against β-lactamase producing Branhamella catarrhalis and Haemophilus influenzae
5. Comparaison de l'activité in vitro des associations amoxicilline + acide clavulanique et ampicilline + sulbactam sur cinquante souches de Haemophilus influenzae productrices d'une bêta-lactamase
6. Activités in vitro de l'amoxicilline et de l'association amoxicilline-acide clavulanique vis-à-vis d' Escherichia coli en médecine de ville
7. Effect of low concentrations of clavulanic acid on the in vitro activity of amoxicillin against β-lactamase producing Branhamella catarrhalis and Haemophilus influenzae
8. Pharmacodynamics (PDs) of Amoxicillin (AMX) - Clavulanic Acid (CA) 1. 125 g orally against β-lactamase producing Haemophilus influenzae
9. Pharmacodynamics of piperacillin alone and combination with tazobactam against piperacillin-resistant and - Susceptible organisms in an in vitro model of infection
10. Détermination de la concentration minimale inhibitrice et de la concentration minimale bactéricide en milieu liquide
11. Post-antibiotic and post-β-lactamase inhibitor effects of amoxicillin plus clavulanate
12. In vitro bacterial killing kinetics of ticarcillin/clavulanic acid
13. Efficacy of twice daily dosing of amoxicillin/clavulanate in acute otitis media in children
14. Single dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients
15. Parenteral augmentin pharmacokinetics
16. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection
17. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against S. aureus: Implications for dosage regimens